MedPath

Epidemiology Study of Keloid

Conditions
Keloid
Registration Number
NCT01423383
Lead Sponsor
Tirgan, Michael H., M.D.
Brief Summary

Although keloid is a very common condition; there are no statistics as to its true incidence and prevalence, neither in United States, nor elsewhere in the world. This trial intends to capture epidemiological data about this disease in a large population sample.

Detailed Description

The purpose of current trial is to establish a robust database of incidence and prevalence of keloid, as well as prevalence of familial keloid, in various ethnic groups. Study sample size is 100,000 random individuals who will fill out either a web survery or a paper questionnaire.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100000
Inclusion Criteria
  1. Informed consent
  2. Age above 18 to answer the survey questions
  3. Parents shall respond on behalf of their minor children
Exclusion Criteria
  • None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevalence of various clinical findings will be determined at the end of Survey.Two Years

This will be a prospective online and paper based survey with an estimated 100,000 responders participating in two years. Statistics will be descriptive. The prevalence of various clinical findings will be determined at the end of Survey. Findings will be correlated with the source of the data, online, or paper questionnaire, as well as the locations where the paper questionnaires surveys were placed.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Michael H. Tirgan, MD

🇺🇸

New York, New York, United States

Michael H. Tirgan, MD
🇺🇸New York, New York, United States
Michael H. Tirgan, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.